share_log

騰盛博藥-B：截至2024年3月31日之股份發行人的證券變動月報表

BRII-B: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

Hong Kong Stock Exchange ·  Apr 26 02:49
Summary by Moomoo AI
腾盛博药生物科技有限公司於2024年4月26日重新提交了截至2024年3月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為1,200,000,000股，面值0.000005美元，總額6,000美元。在股份期權方面，根據首次公開發售股份激勵計劃，本月內有1,500股份期權被行使，而有95,000股份期權失效。此外，首次公開發售後購股權計劃中有987,775股份期權失效。2023年購股權計劃新授出5,752,500股份期權。本月內因行使期權所得資金總額為587.13港元。報告亦提到，有231,625份受限制股份單位於2024年3月失效。公司確認所有證券發行均獲董事會授權，並符合香港聯合交易所有限公司證券上市規則的要求。
腾盛博药生物科技有限公司於2024年4月26日重新提交了截至2024年3月31日的證券變動月報表。報告顯示，公司的法定/註冊股本維持不變，上月底結存及本月底結存均為1,200,000,000股，面值0.000005美元，總額6,000美元。在股份期權方面，根據首次公開發售股份激勵計劃，本月內有1,500股份期權被行使，而有95,000股份期權失效。此外，首次公開發售後購股權計劃中有987,775股份期權失效。2023年購股權計劃新授出5,752,500股份期權。本月內因行使期權所得資金總額為587.13港元。報告亦提到，有231,625份受限制股份單位於2024年3月失效。公司確認所有證券發行均獲董事會授權，並符合香港聯合交易所有限公司證券上市規則的要求。
TENSHENG BO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. REFILED ON APRIL 26, 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED MARCH 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 1,200,000,000 shares outstanding at the end of last month and deposits at the end of this month at $0.00000005 for a total amount of $6,000. In terms of stock options, 1,500 share options were exercised this month under the Initial Public Offering Incentive Scheme, and 95,000 share options expired. In addition, 987,775 share options expired in the Initial Public Offering Post-IPO Share Option Plan. New issuance of 5,752,500 share options under the Share Option Plan 2023. The total amount of capital received from the exercise of options during the month was HK$587.13. The report also noted that 231,625 units of restricted stock matured in March 2024. The Company confirms that all issuance of securities is authorised by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
TENSHENG BO PHARMACEUTICAL BIOTECHNOLOGY CO., LTD. REFILED ON APRIL 26, 2024 THE REPORT ON CHANGES IN SECURITIES FOR THE MONTH ENDED MARCH 31, 2024. The report shows that the company's regulated/registered share capital remained unchanged, with 1,200,000,000 shares outstanding at the end of last month and deposits at the end of this month at $0.00000005 for a total amount of $6,000. In terms of stock options, 1,500 share options were exercised this month under the Initial Public Offering Incentive Scheme, and 95,000 share options expired. In addition, 987,775 share options expired in the Initial Public Offering Post-IPO Share Option Plan. New issuance of 5,752,500 share options under the Share Option Plan 2023. The total amount of capital received from the exercise of options during the month was HK$587.13. The report also noted that 231,625 units of restricted stock matured in March 2024. The Company confirms that all issuance of securities is authorised by the Board of Directors and complies with the requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more